LAUSR

Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism

Sign Up to like & get
recommendations!
1 Published in 2022 at "PLoS ONE"

DOI: 10.1371/journal.pone.0266601

Abstract: Pancreatic cancer is the fourth leading cause of cancer death, with a 5-year survival rate of 10%. A stagnant high mortality rate over the last decades highlights the need for innovative therapeutic approaches. Pancreatic tumors… read more here.

Keywords: metabolism; pancreatic cancer; cpi 613; targeting pancreatic ... See more keywords